Fulgent Genetics Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Fulgent Genetics are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 23, 2019 and ending today September 21, 2019. Click here to learn more.

Fulgent Genetics Summary

Fulgent Genetics (FLGT) is traded on BATS Exchange in USA. It is located in 4978 Santa Anita Avenue and employs 123 people. Fulgent Genetics is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 204.27M. Fulgent Genetics conducts business under Healthcare sector and is part of Diagnostics & Research industry. The entity has 18.49M outstanding shares of which 24.98K shares are currently shorted by private and institutional investors with about 0.37 trading days to cover. FULGENT GENETICS currently holds about 26.98M in cash with 19.12K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.47.
Check Fulgent Genetics Probability Of Bankruptcy

Ownership Allocation (%)

Fulgent Genetics Target Price Odds Analysis

Odds Below 11.16HorizonTargetOdds Above 11.16
80.68%30 days 11.16 19.26%
Based on normal probability distribution, the odds of Fulgent Genetics to move above current price in 30 days from now is about 19.26% (This Fulgent Genetics probability density function shows the probability of Fulgent Genetics Stock to fall within a particular range of prices over 30 days) .

Fulgent Genetics Top Holders

Fulgent Genetics Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Old West Investment Management LlcCommon Shares447.9 K3 M
Mutual Advisors LlcCommon Shares174.9 K1.2 M
View Fulgent Genetics Diagnostics

Fulgent Genetics Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Fulgent Genetics Key Fundamentals

Fulgent Genetics Against Markets

Fulgent Genetics Vital Trading Data

Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. Fulgent Genetics operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 123 people. more
Fama & French Healthcare
Fama & French Classification
Fulgent Genetics SEC Filings
Fulgent Genetics SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameFulgent Genetics
ChairmanMing HsiehView All
Thematic Classification
Currently Active Investing Idea
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Diagnostics & Research
InstrumentUSA Stock View All
LocationCalifornia U.S.A
Business Address4978 Santa Anita Avenue
ExchangeBATS Exchange
IndustryDiagnostics & Research
Phone626 350 0537
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019

Fulgent Genetics Corporate Directors

John Bolger Director
Hanlin Gao Lab Director and Chief Scientific Officer
James Mulay Director
Additionally see Investing Opportunities. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Search macroaxis.com